Gilead's Tecartus gets revised safety demand amid FDA's push for CAR-T boxed warnings

cafead

Administrator
Staff member
  • cafead   Jan 24, 2024 at 11:02: AM
via The FDA’s letter demanding a labeling change for Gilead Sciences’ Tecartus temporarily went missing on the agency’s website Tuesday. Turns out, the FDA didn’t drop the CD19 CAR-T from a classwide safety alert list.

article source